Establishment of a Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay to Measure Soluble B7-H5 in Patients with Cancer

Table 3

The relationship between the levels of sB7-H5 in sera of patients with LC and clinicopathological characteristics.

Characteristics		sB7-H5 expression
		Median (Min–Max)	~
Age
≤67	62	389.2 (134.7-925.2)	338.2-453.6	1588	0.1646
>67	60	415.0 (213.8-1655)	360.5-527.9
Gender
Male	75	403.3 (216.2-1191)	359.8-470.2	1728	0.8576
Female	47	409.1 (134.7-1655)	327.0-492.5
TNM
I+II	32	388.4 (140.6-501.5)	273.1-453.7	1089	0.0405
III+IV	90	409.0 (134.7-1655)	360.3-505.0
Metastasis
No	22	325.6 (140.6-501.5)	247.9-428.7	629.5	0.0014
Yes	100	413.0 (134.7-1655)	360.5-486.7

TNM: tumor node metastasis. ; .